Stock Code 603707.SH

• ABOUT

  >
  Company profile Enterprise Culture Early Warning System
• PRODUCTS

  >
  Product List Commercialized Products
• INNOVATION

  >
  Small Molecule Pharmaceuticals Macromolecule pharmaceuticals Global Regulatory Registration Support Commercial cooperation
• MEDIA

  >
  News in NKF Industry dynamics
• CONTACT

CH / EN

ONCOLOGY

Home  >  PRODUCTS > Commercialized Products > ONCOLOGY

• ANTICOAGULANT
• ANESTHETIC
• ONCOLOGY
• CARDIOVASCULAR
• ENDOCRINE
• ANTI-INFECTIVE
• DIAGNOSIS
• GASTROENTEROLOGY
• WOMEN HEALTH
• MISCELLANEOUS

• 
  Thiotepa for Injection
• 
  Palonosetron HCl Injection
• 
  Plerixafor Injection
• 
  Leucovorin for Injection
• 
  Zoledronic Acid Injection
• 
  Nelarabine Injection
• 
  Mitomycin for Injection
• 
  Gemcitabine HCl for Injection
• 
  Azacitidine for Injection
• 
  Busulfan Injection
• 
  Clofarabine Injection
• 
  Dactinomycin for Injection
• 
  Melphalan for Injection (lyo) kit
• 
  Carmustine for Injection（Kit）
• 
  Decitabine for Injection
• 
  Bendamustine HCl for Injection
• 
  Bortezomib for Injection
• 
  Bleomycin for Injection
• 
  Levoleucovorin Injection
• 
  Cytarabine Injection
• 
  Fulvestrant Injection

• ABOUT
• INNOVATION
• MEDIA
• CONTACT
• PRODUCTS

Stock price

13.700

-0.15

©2024 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd苏ICP备13012010号

• Disclaimers
• Privacy policy
• Site map

XML 地图